| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 01/16/2003 | WO2002059148A8 A method for identification, isolation and production of antigens to a specific pathogen |
| 01/16/2003 | WO2002059147A3 Activatable cytolytic or drug delivery peptides and uses thereof |
| 01/16/2003 | WO2002055685A3 Novel human kinase and polynucleotides encoding the same |
| 01/16/2003 | WO2002055683A3 Galactosyltransferase homolog, znssp11 |
| 01/16/2003 | WO2002053712A3 Avian hepatitis e virus, vaccines and methods of protecting against avian hepatitis-splenomegaly syndrome and mammalian hepatitis e |
| 01/16/2003 | WO2002053701A3 Epididymal lipocalin gene and uses thereof |
| 01/16/2003 | WO2002046387A3 Plant derived hydroxy phenyl pyruvate dioxygenases (hppd) resistant against triketone herbicides and transgenic plants containing these dioxygenases |
| 01/16/2003 | WO2002046362A3 Gene associated with benign prostatic hyperplasia in humans |
| 01/16/2003 | WO2002046223A3 Compositions and methods related to the minn1 tumor suppressor gene and protein |
| 01/16/2003 | WO2002043661A3 Recombinant anti-cd30 antibodies and uses thereof |
| 01/16/2003 | WO2002042445A3 Differentiated cells suitable for human therapy |
| 01/16/2003 | WO2002040633A3 Optimized antitrypsin expression in rice cell culture |
| 01/16/2003 | WO2002040540A3 Artery smooth muscle- and vein smooth muscle-specific proteins and uses therefor |
| 01/16/2003 | WO2002039955A3 Biodegradable mixed polymeric micelles for drug delivery |
| 01/16/2003 | WO2002038587A3 Haplotypes of the grm8 gene |
| 01/16/2003 | WO2002038172A3 Sdf-1 beta expressing tumor cells as tumor vaccines |
| 01/16/2003 | WO2002036743A3 Antisense modulation of calreticulin expression |
| 01/16/2003 | WO2002034769A3 Immunoreactive peptide ctl epitopes of human cytomegalovirus pp150 |
| 01/16/2003 | WO2002033081A3 Veterinary immunisation vectors comprising nucleic acid sequences encoding variants of non-human c3d polypeptides |
| 01/16/2003 | WO2002031144A3 Identification of cytotoxic activity from the ink of aplysia punctata |
| 01/16/2003 | WO2002030944A3 Fluorescent nucleobase conjugates having anionic linkers |
| 01/16/2003 | WO2002029030A3 Ethanol production |
| 01/16/2003 | WO2002029026A3 Human proteases and polynucleotides encoding the same |
| 01/16/2003 | WO2002029018A3 Divinyl ether synthase gene and protein, and uses thereof |
| 01/16/2003 | WO2002026819A3 Recombinant bcg vaccines for the prevention and treatment of cancer |
| 01/16/2003 | WO2002022808A3 Cripto mutant and uses thereof |
| 01/16/2003 | WO2002022806A3 Isolated human phospholipase proteins, nucleic acid molecules encoding human phospholipase proteins, and uses tehreof |
| 01/16/2003 | WO2002022080A8 Enhanced first generation adenovirus vaccines expressing codon optimized hiv1-gag, pol, nef and modifications |
| 01/16/2003 | WO2002021141A3 Methods and compositions for diseases associated with amyloidosis |
| 01/16/2003 | WO2002020813A3 Recombinant endothelial cell growth inhibitors derived from a mammalian plasminogen |
| 01/16/2003 | WO2002020179A3 Modified carbon, silicon and germanium surfaces |
| 01/16/2003 | WO2002019811A3 Generation of transgenic animals using nuclear transfer and oocytes at the germinal vesicle stage |
| 01/16/2003 | WO2002018609A3 Methods for stable transduction of cells with viral vectors |
| 01/16/2003 | WO2002018584A3 Xage-1, a gene expressed in multiple cancers, and uses thereof |
| 01/16/2003 | WO2002016616A3 Human carboxylesterase family member and uses thereof |
| 01/16/2003 | WO2002016595A3 Kidney-specific protein |
| 01/16/2003 | WO2002016587A3 Microtubule-associated proteins and tubulins |
| 01/16/2003 | WO2002016581A3 Compositions and methods for the diagnosis and treatment of tumor |
| 01/16/2003 | WO2002016578A3 Secreted proteins and methods of using same |
| 01/16/2003 | WO2002014352A3 Therapeutic compounds for ovarian cancer |
| 01/16/2003 | WO2002010406A3 Metalloproteinase-disintegrin polypeptides and methods of making and use thereof |
| 01/16/2003 | WO2002010200A3 Pas domain proteins |
| 01/16/2003 | WO2002008403A3 Nucleic acid sequences encoding beta-ketoacyl-acp synthase and uses thereof |
| 01/16/2003 | WO2002008275A3 Genes expressed in obese rat hypothalamus |
| 01/16/2003 | WO2002006465A3 7677, a novel human atpase family member and uses therefor |
| 01/16/2003 | WO2002006443A3 Lipoxygenase-inducible promoter, expression cassettes comprising same and transformed plants |
| 01/16/2003 | WO2002002783A3 Expression vectors |
| 01/16/2003 | WO2002002772A3 Human extracellular matrix (ecm)-related tumor marker |
| 01/16/2003 | WO2002002604A3 Leucine-rich repeat proteins, zlrr7, zlrr8 and zlrr9 |
| 01/16/2003 | WO2001098323A8 G-protein coupled receptors |
| 01/16/2003 | WO2001094584A3 21784, a novel human calcium channel family member and uses thereof |
| 01/16/2003 | WO2001093913A3 T cell receptor fusions and conjugates and methods of use thereof |
| 01/16/2003 | WO2001092549A3 Method and composition for targeting an adenoviral vector |
| 01/16/2003 | WO2001092539A3 Method for the production of p-hydroxybenzoate in species of pseudomonas and agrobacterium |
| 01/16/2003 | WO2001092490A3 Isolated human aminotransferase proteins, nucleic acid molecules encoding human aminotransferase proteins, and uses thereof |
| 01/16/2003 | WO2001091739A3 Compositions and methods for treating neoplastic disease using chemotherapy and radiation sensitizers |
| 01/16/2003 | WO2001090192A3 Bispecific immunoglobulin-like antigen binding proteins and method of production |
| 01/16/2003 | WO2001090156A3 Card domain containing polypeptides, encoding nucleic acids, and methods of use |
| 01/16/2003 | WO2001087937A3 G-protein coupled receptors |
| 01/16/2003 | WO2001086297A3 Methods of identifying the activity of gene products |
| 01/16/2003 | WO2001085941A9 Myc targets |
| 01/16/2003 | WO2001085767A3 Human proteins polynucleotides encoding them and methods of using the same |
| 01/16/2003 | WO2001081375A9 Dna & protein binding miniature proteins |
| 01/16/2003 | WO2001079857A3 System and method for treatment of samples on solid supports |
| 01/16/2003 | WO2001079538A3 Cell-binding nucleic acid molecules (aptamers) |
| 01/16/2003 | WO2001077153A3 Phage display selection of anti fungal peptides |
| 01/16/2003 | WO2001074901A3 Polynucleotides and polypeptides, their use in diagnosis and treatment of cardiac, renal or inflammary disease |
| 01/16/2003 | WO2001071013A3 Melon promoters for expression of transgenes in plants |
| 01/16/2003 | WO2001071009A3 Whole-body optical imaging of gene expression and uses thereof |
| 01/16/2003 | WO2001070980A9 Isolated g-protein coupled receptors, nucleic acid molecules encoding gpcr proteins, and uses thereof as insecticidal targets |
| 01/16/2003 | WO2001070174A8 Vegf-modulated genes and methods employing them |
| 01/16/2003 | WO2001068880A9 Estrogen-regulated myo-inositol phosphate synthase: compositions and methods of use |
| 01/16/2003 | WO2001068806A9 26934, a novel cytidine deaminase-like molecule and uses thereof |
| 01/16/2003 | WO2001068805A9 Human olfactory receptors and genes encoding same |
| 01/16/2003 | WO2001066717A9 Gene targeting method |
| 01/16/2003 | WO2001064944A9 MODULATION OF PLEIOTROPHIN SIGNALING BY RECEPTOR-TYPE PROTEIN TYROSINE PHOSPHATASE β/$g(z) |
| 01/16/2003 | WO2001064913A9 Cell cycle proteins associated with rad9, compositions and methods of use |
| 01/16/2003 | WO2001064882A9 1983, 52881, 2398, 45449, 50289, and 52872, g protein-coupled receptors and uses therefor |
| 01/16/2003 | WO2001064880A9 Human dynamin 40322 |
| 01/16/2003 | WO2001059093A9 Full-length infectious cdna clones of tick borne flavivirus |
| 01/16/2003 | WO2001058954A9 Trade molecules and uses related thereto |
| 01/16/2003 | WO2001058946A9 Polynucleotides and polypeptides encoded thereby |
| 01/16/2003 | WO2001055409A9 Microbes and methods for remediation |
| 01/16/2003 | WO2001053340A9 Transgenic mouse model of human neurodegenerative disease |
| 01/16/2003 | WO2001052868A9 Combinations for treating neoplasms |
| 01/16/2003 | US20030014777 Method and means for modulating plant cell cycle proteins and their use in plant cell growth control |
| 01/16/2003 | US20030014776 Nucleotide sequences coding plant regultory sequence for use in controlling apomixis in plants |
| 01/16/2003 | US20030014775 Compositions and method for modulation of gene expression in plants |
| 01/16/2003 | US20030014774 Transgenic rice plant and its family with environmental stress resistant by proline accumulation of high level and its production |
| 01/16/2003 | US20030014772 Transgenic mice containing MSK2 serine/threonine kinase gene disruptions |
| 01/16/2003 | US20030014771 Transgenic mice containing USP3-like deubiquitinating enzyme gene disruptions |
| 01/16/2003 | US20030014770 Alpha (1,3) galactosyl transferase negative swine |
| 01/16/2003 | US20030014769 Transgenic animal for us eas tool in the dianosis and treatment of nervous system and psychological disorders |
| 01/16/2003 | US20030014232 Methods for predicting biological activities of cellular constituents |
| 01/16/2003 | US20030013867 Translation enhancer element of the human amyloid precursor protein gene |
| 01/16/2003 | US20030013866 Eukaryotic cells expressing the receptor |
| 01/16/2003 | US20030013865 Novel human EGF-family proteins and polynucleotides encoding the same |
| 01/16/2003 | US20030013863 Sequencing reaction is prepared using a DNA template that has multiple copies of a a nucleotide motif sequence and a dideoxy nucleotide terminator |
| 01/16/2003 | US20030013850 Antiinflammatory agents |
| 01/16/2003 | US20030013755 Autoinducer compounds |